Find the right fit for you - faster
Get tailored insights about working at Sensei Biotherapeutics in one quick step.
Sensei Biotherapeutics Snapshot
We push the boundaries of science and imagination to discover and develop innovative medicines for patients. Sensei biotherapeutics is developing a pipeline of medicines designed to fulfill the substantial potential of the immune system to defeat cancer and other diseases.
Sensei stands for teacher. We are teaching the immune system to fight cancer and other diseases. Ours is a collaborative and teaching culture where impassioned people are expected to bring their experience and ideas to the mission to contribute to the greater good.
We are a small but growing company with an exciting and unique scientific mission. Sensei’s approach is novel, and we are looking to add to more team members that are energized by a challenge and open to reach beyond expectations. No matter your role at Sensei, you are a critical contributor to the organization’s mission.
Sensei stands for teacher. We are teaching the immune system to fight cancer and other diseases. Ours is a collaborative and teaching culture where impassioned people are expected to bring their experience and ideas to the mission to contribute to the greater good.
We are a small but growing company with an exciting and unique scientific mission. Sensei’s approach is novel, and we are looking to add to more team members that are energized by a challenge and open to reach beyond expectations. No matter your role at Sensei, you are a critical contributor to the organization’s mission.
We are Sensei Bio
We are developing a pipeline of medicines designed to fulfill the substantial potential of the immune system to defeat cancer and other diseases. We have developed two unique approaches – our ImmunoPhage™ platform and our monoclonal antibody and nanobody platform. Our proprietary ImmunoPhage™ platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused and coordinated innate and adaptive immune response.
We are developing a pipeline of medicines designed to fulfill the substantial potential of the immune system to defeat cancer and other diseases. We have developed two unique approaches – our ImmunoPhage™ platform and our monoclonal antibody and nanobody platform. Our proprietary ImmunoPhage™ platform is a powerful, self-adjuvanted and highly differentiated immunotherapy approach that is designed to utilize bacteriophage to induce a robust, focused and coordinated innate and adaptive immune response.
